ArticleNeuro-oncology2025

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.

Martha Foltyn-Dumitru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.